DBT has strategic partnership with Australia for fostering research in the medical biotechnology domain. The Indo-Australian Biotechnology Fund is managed jointly by the Department of Biotechnology (DBT), Government of India and Department of Industry, Innovation and Science (DIIS), Govt. of Australia. Since its inception in 2006, the IABF has supported collaborative, leading-edge research between scientists in Australia and India across a range of jointly agreed priority areas. It has also helped to build linkages between premier research and educational institutions in both countries. The Indo-Australian Biotechnology Fund (IABF) supports Indian and Australian Scientists, from both the public and private sectors, to collaborate in cutting edge research in the area of science & technology.

The purpose of the call is to support research and innovation projects that are highly relevant for scientific solution for biomanufacturing, biotechnology for improved agricultural productivity and climate resilience, RNA vaccines and biotherapeutics. The call seeks to fund applications for conducting research with a high societal relevance, both basic and applied, and innovation promoting the transition, nationally in India and Australia, as well as internationally. The priority areas of research for Round sixteen of the Indo-Australian Biotechnology Fund are:

Indo-Australian Biotechnology Fund (administered by the Department of Biotechnology (DBT) in India)

• biomanufacturing for industrial and consumer products, including biochemicals, biofuels and novel bio-based materials
• biotechnology for improved agricultural productivity and climate resilience (including food security or renewable feedstocks)
• RNA vaccines and biotherapeutics (immunotherapy)

For more details click here